Vicarious Surgical Inc expected to post a loss of $2.69 a share - Earnings Preview

Vicarious Surgical

28/02/2025 11:10

Vicarious Surgical Inc RBOT.N, RBOT.K is expected to show no change in quarterly revenue when it reports  results on March 3 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for Vicarious Surgical Inc is for a loss of $2.69 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Vicarious Surgical Inc is $11.75​, below​ its last closing price of $11.80. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-2.56
-2.55
-2.90
Missed
-13.5
Jun. 30 2024
-2.81
-2.77
-2.59
Beat
6.7
Mar. 31 2024
-2.81
-2.85
-3.00
Missed
-5.3​
Dec. 31 2023
-3.73
-3.75
-1.80
Beat
52
​​Sep. 30 2023
-3.95
-4.27
-3.00
Beat
29.8
Jun. 30 2023
-4.44
-4.27
-3.60
Beat
15.8​
Mar. 31 2023
-4.05
-4.05
-6.30
Missed
-55.6
Dec. 31 2022
-5.40
-5.20
-2.70
Beat
48.1

This summary was machine generated February 28 at 11:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)